Skip to main content
Equibles
HCA logo

HCA · HCA Healthcare, Inc. · Metrics

Track HCA — free

Use HCA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HCA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$465.75 +10.87 (+2.39%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$100.91B
Shares
221.84M
Volume · Oct 20 1.32M Avg daily vol (3M) 1.36M

HCA metrics

94 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$454.88
Market cap
$100.91B

Price action

20 metrics
Price change (1W)
-0.8%
Price change (30D)
+6.8%
Price change (3M)
+22.8%
Price change (6M)
-4.9%
Price change (YTD)
-2.6%
Price change (1Y)
+6.7%
Trailing year
Price change (5Y)
+82.9%
52-week high
$545.13
52-week low
$361.32
Change from 52-week high
-16.6%
Change from 52-week low
+25.9%
Annualized volatility
31.2%
Annualized volatility (3M)
29.6%
Beta
0.2
RSI (14D)
59.8
Price vs SMA 50
+6.4%
Price vs SMA 200
+2.3%
Avg volume (3M)
1.36M
Relative volume
0.7
Average dollar volume
$567.92M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
221.84M

Valuation

12 metrics
P / E (TTM)
15.3
Trailing earnings · reciprocal yield 6.6%
PEG ratio
1.3
EV / revenue
1.9×
reciprocal yield 51.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.3×
reciprocal yield 76.6%
P / book
—
FCF yield
5.9%
TTM · current market cap
Buyback yield
8.5%
P / FCF
17.0
reciprocal yield 5.9%
P / operating cash flow
9.2
reciprocal yield 10.9%
Earnings yield
6.7%

Historical valuation

8 metrics
P / E historical average (3Y)
15.3×
reciprocal yield 6.5%
P / E historical average (5Y)
14.3×
reciprocal yield 7.0%
EV / revenue historical average (3Y)
1.8×
reciprocal yield 54.5%
EV / revenue historical average (5Y)
1.7×
reciprocal yield 60.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.7%
Trailing 12 months
Payout ratio
10.0%
Shareholder yield
9.2%
Dividend / share (TTM)
$3.06
Dividend growth YoY
+8.5%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-16

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-24

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
8.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$6.84B
Trailing 12 months
Diluted EPS (TTM)
$29.82
FCF margin
7.7%
Effective tax rate
20.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$340.81
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$29.87
Operating cash flow per diluted share (TTM)
$48.29
Free cash flow per diluted share (TTM)
$25.92
Capital expenditures per diluted share (TTM)
$22.37
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.63
Book value per share
$-30.47

Growth

11 metrics
Revenue growth YoY
+8.7%
Year over year
Net income growth YoY
+2.8%
Revenue (TTM)
$78.01B
Trailing 12 months
EPS growth YoY
+11.6%
Shares change YoY
-7.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.9%
Revenue CAGR (5Y)
+8.0%
EPS CAGR (3Y)
+13.9%
EPS CAGR (5Y)
+21.0%
FCF CAGR (3Y)
+23.1%
FCF CAGR (5Y)
+3.8%

Quality

14 metrics
Return on equity
—
Return on assets
10.8%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
—
Free cash flow (TTM)
$6.00B
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$48.70B
Latest balance sheet
Cash & equivalents
$1.01B
Total assets
$63.25B
Total debt
$49.72B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$11.12B
Capital expenditures (TTM)
$5.13B
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$375.00M
R&D / revenue
—
Stock compensation / revenue
0.5%

Ownership (13F)

9 metrics
13F filers
1,352
13F filer change QoQ
-83
Institutional ownership
60.1%
Conviction holders (share of 13F filers)
1.5%
Crowding (high-turnover and private-fund holders)
13.2%
Private-fund adviser ownership
12.9%
Active holders' share change QoQ
-1.7%
Holder tenure
18.3
Price vs estimated holder cost
-1.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.0%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 3.1 days to cover
Days to cover
3.1d
Short-squeeze score
44 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 860730 CUSIP 40412C101 13F (30d) 215 filings 200 filers Visit website Investor relations